Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Molecular Cancer Therapeutics|March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the youngAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Nature Communications|January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signallingSteven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Pageof 22